entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 00:46:10 - browse：5766

A phone screen displays the webpage of Medicare.gov — coverage from STAT — Adobe

Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them higher payment rates for next year. The government’s data on how much people were using health care didn’t match their own data, insurers and lobbyists griped — and therefore they wouldn’t be paid enough to cover those costs.

But the federal government was not persuaded by the industry’s data or lobbying push. The Biden administration and its Medicare agency decided to stick with their proposals from January on Monday, dealing a blow to an insurance industry that has come to rely on Medicare Advantage for a steady stream of profits.

The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities. The stock prices of the largest Medicare Advantage insurers — UnitedHealth, Humana, CVS Health, and Elevance Health — all fell by at least 4% in after-hours trading.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Fatty liver disease was alleviated by Lilly’s ‘triple

hotspot

WSS

Security flaws in third

WuXi Biologics execs register to lobby as Congress comes for the company

Skip the lead apron during X

As H5N1 spreads in cows, experts warn against drinking raw milk

Ripples from Flovent's discontinuation is killing children with asthma

Cherokee Nation medical school graduates its first class

leisure time

entertainment

Wikipedia

How to save PrEP access — and even expand it

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Alkermes shareholders re

Novo Nordisk testing Wegovy against alcohol

Apple is now the first public company to be valued at $3 trillion

Crowdfunding for unproven stem cell procedures spreads misinformation

Dobbs anniversary: the lost opportunity of abortion as health care

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

In Memoriam: Notable people who died in 2023

The wait for US passports is creating travel purgatory and snarling summer plans

leisure time

AstraZeneca lung cancer study comes in below expectations

The biotech scorecard for Q3: 15 stock

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Being 'nonadherent' patient made me a more empathetic doctor

STAT reporters are Pulitzer Prize finalists for investigative reporting

Obesity drug from Roche shows promise in early study

focus

hotspot

hotspot

hotspot